TTAB Posts September 2014 Hearing Schedule
The Trademark Trial and Appeal Board has scheduled five (5) oral hearings for the month of September, as listed below. The hearings will be held in the East Wing of the Madison Building, in Alexandria, Virginia. The hearing schedule and other details regarding attendance may be found at the TTAB website (lower right-hand corner)]. Briefs and other papers for these cases may be found at TTABVUE via the links provided.
September 3, 2014 - 10 AM: In re Seacret International LTC, Serial No. 78811559 [Section 2(d) refusal to register SEACRET (in stylized form) for "products containing ingredients from the Dead Sea, namely, non-medicated skin care preparations, namely, moisturizers, facial cleansers, facial peels, masks, lotions, creams , scrubs, soaps, nail care preparations, hand creams, cuticle oils; after shave," in view of the registered mark SECRET for body spray, antiperspirant, and deodorant].
September 18, 2014 - 3 PM: The North Face Apparel Corp. v. Sanyang Industry Co. Ltd., Opposition No. 91187593 [Section 2(d) opposition to registration of the mark shown below left for a variety of goods and services in classes 7, 11, 12, 16, 25, 35, and 37, including motorcycles, lawnmowers, clothing (including shirts and coats), and auto repair services, in view of the registered mark shown below right, for footwear, backpacks, sleeping bags, and clothing (including shirts and coats)].
September 23, 2014 - 2 PM: In re CTI Electronics Corporation, Serial No. 85150436 [Refusal to register INDUSTRIAL MOUSE on the Supplemental Register, for "inductive joystick cursor controller, namely heavy duty computer pointer" on the ground of genericness].
September 24, 2014 - 10 AM: In re Mannatech, Incorporated, Serial No. 85558774 [Section 2(d) refusal to register NUTRIVERUS for dietary and nutritional supplements, on the ground of likelihood of confusion with the registered marks NU VERUS & Design for "liquid nutritional supplement; nutritional supplements; vitamin and mineral supplements," and VERUS PHARMACEUTICALS & Design for "pharmaceutical products primarily intended for pediatric use for treating asthma, allergies and related respiratory diseases and conditions; auto-injectors containing epinephrine for treatment of anaphylactic reactions"].
September 24, 2014 - 2 PM: In re Ren Acquisition, Inc., Serial Nos. 85787527 and 85787531 [Section 2(e)(1) mere descriptiveness refusal of BLENDS and BLENDS, INC. for "marketing, advertising, and promoting the sale of wine"].
Read comments and post your comment here.
TTABlog note: Any predictions? See any "WYHA"s or "WYHO"s here?
Text Copyright John L. Welch 2014.